Dyslipidemia Flashcards

1
Q

What are the causes of dyslipidemia?

A

PRIMARY

  • single of multiple gene mutation
  • over production or defective clearance of triglycerides & LDL, underproduction or excessive clearance of HDL

SECONDARY

  • sedentary life style
  • Diet: excessive intake of saturated fat, alcohol consumption
  • Drugs: thiazides, retinoids, antiretroviral agents, cyclosporin, tacrolimus, estrogen & progestins, & glucocorticoids
  • Disease: diabetes, hypothyroidism, obesity, chronic liver disease, primary biliary cirrhosis, chronic renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are triglycerides stored?

A

in adipocytes & muscle cells

store unused calories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the physiology of lipid digestion?

A

1- dietary triglycerides are digested in the stomach & duodenum by gastric lipase, stomach peristalsis, & pancreatic lipase INTO monoglycerides & FFAs

2- monoglycerides, FFA, & free cholesterol are solubilized in the intestine by bile acid -> absorbed into intestinal villi

3- in enterocytes they are reassembled into TGs & packaged with cholesterol into chylomicrons

4- chylomicrons transport dietary TGs & cholesterol into the circulation

5- Apolipoprotein C-II (apo C-II) on chylomicron activates endothelial lipoprotein lipase (LPL)

6- LPL converts the TGs in chylomicron to fatty acids & glycerol

7- fatty acids & glycerol are taken up by adipocytes & muscle cells for energy use or storage

8- cholesterol rich chylomicron remnants circulate back to the liver to be cleared by apolipoprotein E (apo E)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the largest lipoprotein?

A

Chylomicrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What leads to elevated plasma cholesterol & TG levels?

A

stimulation of hepatic lipoprotein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the function of VLDL?

A
  • contains apolipoprotein B-100
  • synthesized in the liver & transports TGs & cholesterol to peripheral tissue
  • its synthesis increases with increased intrahepatic FFA (to export excess TG out of the liver)
  • apoprotein C-II -> activates LPL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the function of IDL?

A
  • product of LPL processing of VLDV & chylomicrons

- either cleared by the liver or metabolized by hepatic lipase into LDL (retains apo B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of LDL?

A
  • the MOST CHOLESTEROL RICH of all lipoproteins
  • product of VLDL & IDL metabolism
  • 40 - 60% of all LDL are cleared by the liver by apo B & hepatic LDL receptors
  • hepatic LDL receptors are down-regulated by increased dietary saturated fat intake & chylomicrons
  • hepatic LDL receptors are up-regulated by decreased dietary fat & cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of HDL?

A
  • synthesized in enterocytes & liver
  • obtains cholesterol from peripheral tissues & other lipoproteins & transport it to the liver for clearance
  • ANTI-ATHEROGENIC EFFECT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is lipoprotein a?

A
  • an LDL that contains apoprotein a
  • inhibits fibrinolysis -> promotes thrombus formation
  • directly promotes atherosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of PCSK9?

A
  • regulates levels of LDL receptors
  • binds to LDL receptors -> stops LDL from being removed from the blood -> increased LDL levels
  • gain of function mutations -> reduce LDL receptors in the liver -> high levels of plasma LDL -> increased susceptibility to coronary heart disease
  • loss of function mutations -> higher levels of LDL receptors -> lower plasma LDL -> protection from coronary heart disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the genetic classification of dyslipidemias?

A

TYPE I - chylomicronemia syndrome

  • LPL or ApoCII genetic defect
  • Triglyceride levels -> 1000 - 10 000
  • eruptive xanthomas & pancreatitis

TYPE IIa - increased LDL

  • polygenic hypercholesterolemia: LDL-C > 130
  • > increased risk of ASCVD
  • heterogenous familial hypercholesterolemia: LDL-C > 190
  • homogenous familial hypercholesterolemia: LDL-C > 350
  • > increased risk of premature ASCVD
  • > tendon xanthoma

TYPE IV - increased triglycerides & VLDL

  • familial hypertriglyceridemia
  • TG > 150
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What levels of triglyceride could lead to acute pancreatitis?

A

> 500mg/dL (>5.65 mmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the signs & symptoms of high LDL levels?

A
  • corneal arcus
  • xanthelasma
  • tendon xanthomas -> at achilles, elbow, knee tendons, & over metacarpophalageal joints
  • tuberous xanthomas -> painless, firm nodules located over extensor surfaces of joints
  • eruptive xanthomas -> over the trunk, back, elbows, buttocks, knees, hands, & feet
  • severe elevations of TGs can give a lactescent (milky) appearance to blood plasma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should be done to diagnose dyslipidemia?

A
  • serum lipid profile (total cholesterol, TG, HDL & calculated LDL) -> measured while fasting for 12 hours for maximum accuracy
  • non-HDL cholesterol (TC - HDL cholesterol) can be measured without fasting -> predictive of CAD risk (N < 130)
  • TC/HDL ratio -> predicts risk of ischemic heart disease (N < 5)
  • Lp(a) is checked in patients with premature atherosclerotic cardiovascular disease but normal or near normal lipid levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

primary lipid disorders should be suspected in which patients?

A
  • physical signs of dyslipidemia
  • premature atherosclerotic disease (< 60 years)
  • family history of atherosclerotic disease
  • serum cholesterol > 240 mg/dL
17
Q

When should screening for dyslipidemia begin?

A

at 20 years & every 5 years after

18
Q

What is the goal of treatment?

A

Primary prevention of ASCVD

Secondary prevention for all patient with ASCVD

19
Q

What is used for treatment go high levels of LDL?

A
  • Diet:
  • Exercise
  • STATINS (treatment of choice)
  • Cholesterol absorption inhibitors -> EZETIMIBE
  • PCSK9 monoclonal antibodies
20
Q

Statins are indicated in which patients?

A
  • history of ASCVD
  • adult with LDL > 190mg
  • age 40 - 75 & LDL is 70 - 189 with diabetes
  • age 40 - 75 & LDL is 70 - 189 with estimated 10-year risk of ASCVD >7.5%
21
Q

What is the function of Statins?

A
  • inhibits hydroxymethylglutaryl CoA reductase -> up regulation of LDL hepatic receptors
  • reduces LDL levels by 60%
  • produces small increases in HDL & decreases in TGs

goals

  • lower LDL > 50%
  • keep LDL < 100 in low risk patients (ASCVD risk < 20%)
  • keep LDL < 70 in high risk patients (ASCVD risk >20%)
  • additional therapy if goals are not reached
22
Q

What are the side effects & contraindications for statins?

A
  • liver enzyme elevations
  • myositis
  • rhabdomyolysis

contraindicated in pregnancy

23
Q

What is the function of Ezetimibe?

A

inhibits intestinal absorption of cholesterol

  • lowers LDL by 15 - 20%
  • could be used as mono-therapy in patients intolerant to statins
24
Q

What is the function of PCSK9 monoclonal antibodies?

A
  • prevents PCSK9 from attaching to LDL receptors
  • subcutaneous injections once or twice per month
  • LDL cholesterol lowered by 40 - 70%
25
Q

How are elevated level of triglycerides treated?

A
  • diet & exercise

FIBRATES (of choice)

  • reduce TGs by 50%
  • stimulate LPL -> increased fatty acid oxidation in the liver & muscle, decreased hepatic VLDL synthesis
  • increases HDL by 20%
  • CAUSES MUSCLE TOXICITY with statins

OMEGA 3 FATTY ACIDS (of choice)
indicated for
- triglyceride levels > 150 in diabetic patients
- > 500 in non diabetic patients

STATINS
- high TGs < 500 IF LDL cholesterol elevations are also present